ACTA PHYSIOL 润色咨询

Acta Physiologica

出版年份:2006 年文章数:1015 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:28.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2022-07-20 ms2000002110695235

    送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2023-11-21 ms8000001482504667 来自天津

    10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2023-11-28 197184_0766 来自天津

    外审四十多天了还没消息

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2022-12-03 1487c177m86(暂无昵称)

    审稿速度:24.0 | 投稿命中率:25.0
    经验分享:审稿要求很多,图片质量,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2018-03-22 ms5663569584175544

    感觉有一定难度,反复修改后录用

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-11-19 121bddc4m20(暂无昵称)

    你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?180****0065暂无昵称 2019-06-01 发表::
    你好,这个杂志非OA,版面费怎么样?
    180****0065暂无昵称 2019-06-01 00:00:00 发表:
    你好,这个杂志非OA,版面费怎么样?

    180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2020-03-04 吃蜜的熊

    这么高接受率么?咋这么胖啊 2020-01-11 发表::
    接收率:约50% 我也想投
    咋这么胖啊 2020-01-11 00:00:00 发表:
    我也想投

    咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2020-01-11 咋这么胖啊

    投稿命中率:50.0
    经验分享:我也想投

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-11-19 121bddc4m20(暂无昵称)

    你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?Huyuandoctor 2018-10-22 发表::
    研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿
    Huyuandoctor 2018-10-22 20:58:00 发表:
    这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿

    Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1233681, encodeId=826c12336812f, content=送审很快,审稿2个月给拒了,审稿人提了很多文章措辞,图片单位,定量结果的问题,对补充实验反而要求不多,文章一定要仔细修改才投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8eb6468300, createdName=ms2000002110695235, createdTime=Wed Jul 20 19:31:39 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170078, encodeId=42e921e007801, content=10月22号给了稿号,第二天就under review,到现在1个月了,还是under review,这个杂志都是这么慢的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc498188271, createdName=ms8000001482504667, createdTime=Tue Nov 21 21:34:51 CST 2023, time=2023-11-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2171499, encodeId=cb8521e14993a, content=外审四十多天了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ad96296901, createdName=197184_0766, createdTime=Tue Nov 28 16:51:24 CST 2023, time=2023-11-28, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2104119, encodeId=65db210411956, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:审稿要求很多,图片质量,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=978e5307095, createdName=1487c177m86(暂无昵称), createdTime=Sat Dec 03 19:43:27 CST 2022, time=2022-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841711, encodeId=c3fb841e1193, content=感觉有一定难度,反复修改后录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Mar 22 10:43:43 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580088, encodeId=66515800886e, content=你好,我也写了篇免疫综述,也想投这个杂志,前辈能不能给点建议呢?<span class="quote">180****0065暂无昵称 2019-06-01 发表::<br>你好,这个杂志非OA,版面费怎么样?</span><span class="quote">180****0065暂无昵称 2019-06-01 00:00:00 发表:<br>你好,这个杂志非OA,版面费怎么样?</span>, beContent=180****0065暂无昵称 2019-06-01 发表:: 你好,这个杂志非OA,版面费怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585872, encodeId=f8ac5858e228, content=这么高接受率么?<span class="quote">咋这么胖啊 2020-01-11 发表::<br>接收率:约50% 我也想投 </span><span class="quote">咋这么胖啊 2020-01-11 00:00:00 发表:<br>我也想投 </span>, beContent=咋这么胖啊 2020-01-11 发表:: 接收率:约50% 我也想投 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=142d2287745, createdName=吃蜜的熊, createdTime=Wed Mar 04 00:00:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583123, encodeId=f30158312302, content=投稿命中率:50.0<br>经验分享:我也想投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4585246030, createdName=咋这么胖啊, createdTime=Sat Jan 11 00:00:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580089, encodeId=4d24580089cb, content=你好,我也写了篇免疫综述,想投贵刊,前辈可不可以告知点经验?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571771, encodeId=6a7c5e177135, content=你好,这个杂志非OA,版面费怎么样?<span class="quote">Huyuandoctor 2018-10-22 发表::<br>研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span><span class="quote">Huyuandoctor 2018-10-22 20:58:00 发表:<br>这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿</span>, beContent=Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ed2557795, createdName=12556906m65暂无昵称, createdTime=Sat Jun 01 00:00:00 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-06-01 12556906m65暂无昵称

    你好,这个杂志非OA,版面费怎么样?Huyuandoctor 2018-10-22 发表::
    研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿
    Huyuandoctor 2018-10-22 20:58:00 发表:
    这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿

    Huyuandoctor 2018-10-22 发表:: 研究方向:免疫;; 接收率:约25% 审稿时间:约2个月 这个杂志目前影响高涨,导致了稿件量大量增加。杂志是英国出版商,牛津出版。感觉还是蛮好。审稿过程十分严格。刚接受了一篇综述。杂志社还会帮助你修改相关的图表,可以多尝试投稿

    0

共28条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分